EdgarLookup

AFLAC INC — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that AFLAC INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
21.2%
Profit Margin
Net income ÷ revenue
3.1%
Return on Assets
Net income ÷ assets
2.95x
Debt-to-Equity
Total liabilities ÷ equity
-9.3%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $17.16B Feb 25, 2026
FY2025 Dec 31, 2024 $18.93B Feb 25, 2026
FY2023 Dec 31, 2023 $3.78B Feb 22, 2024
FY2023 Sep 30, 2023 $4.95B Feb 22, 2024
FY2023 Jun 30, 2023 $5.17B Feb 22, 2024
FY2023 Mar 31, 2023 $4.80B Feb 22, 2024
FY2023 Dec 31, 2022 $3.95B Feb 22, 2024
FY2023 Sep 30, 2022 $4.70B Feb 22, 2024
FY2023 Jun 30, 2022 $5.32B Feb 22, 2024
FY2023 Mar 31, 2022 $5.17B Feb 22, 2024

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $3.65B Feb 25, 2026
FY2025 Dec 31, 2024 $5.44B Feb 25, 2026
FY2025 Dec 31, 2023 $4.66B Feb 25, 2026
FY2024 Dec 31, 2022 $4.42B Feb 26, 2025
FY2023 Dec 31, 2021 $4.23B Feb 22, 2024
FY2022 Dec 31, 2020 $4.78B Feb 24, 2023
FY2021 Dec 31, 2019 $3.30B Feb 23, 2022
FY2020 Dec 31, 2018 $2.92B Feb 23, 2021
FY2019 Dec 31, 2017 $4.60B Feb 21, 2020
FY2018 Dec 31, 2016 $2.66B Feb 25, 2019

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2022 Dec 31, 2022 $4.16B Feb 24, 2023
FY2022 Dec 31, 2021 $4.93B Feb 24, 2023
FY2022 Dec 31, 2020 $4.42B Feb 24, 2023
FY2021 Dec 31, 2019 $4.46B Feb 23, 2022
FY2020 Dec 31, 2018 $4.35B Feb 23, 2021
FY2019 Dec 31, 2017 $4.09B Feb 21, 2020
FY2018 Dec 31, 2016 $4.12B Feb 25, 2019
FY2017 Dec 31, 2015 $4.00B Feb 23, 2018
FY2016 Dec 31, 2014 $4.25B Feb 24, 2017
FY2015 Dec 31, 2013 $4.40B Feb 25, 2016

SG&A Expense

Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $3.25B Feb 25, 2026
FY2025 Dec 31, 2024 $3.01B Feb 25, 2026
FY2025 Dec 31, 2023 $3.17B Feb 25, 2026
FY2024 Dec 31, 2022 $3.25B Feb 26, 2025
FY2023 Dec 31, 2021 $3.54B Feb 22, 2024
FY2022 Dec 31, 2020 $3.42B Feb 24, 2023
FY2021 Dec 31, 2019 $3.09B Feb 23, 2022
FY2020 Dec 31, 2018 $2.99B Feb 23, 2021
FY2019 Dec 31, 2017 $2.78B Feb 21, 2020
FY2018 Dec 31, 2016 $2.80B Feb 25, 2019

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $2.56B Feb 25, 2026
FY2025 Dec 31, 2024 $2.71B Feb 25, 2026
FY2025 Dec 31, 2023 $3.19B Feb 25, 2026
FY2024 Dec 31, 2022 $3.88B Feb 26, 2025
FY2023 Dec 31, 2021 $5.05B Feb 22, 2024
FY2022 Dec 31, 2020 $5.96B Feb 24, 2023
FY2021 Dec 31, 2019 $5.46B Feb 23, 2022
FY2020 Dec 31, 2018 $6.01B Feb 23, 2021
FY2019 Dec 31, 2017 $6.13B Feb 21, 2020
FY2018 Dec 31, 2016 $5.99B Feb 25, 2019

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $116.47B Feb 25, 2026
FY2025 Dec 31, 2024 $117.57B Feb 25, 2026
FY2024 Dec 31, 2023 $126.72B Feb 26, 2025
FY2023 Dec 31, 2022 $131.74B Feb 22, 2024
FY2022 Dec 31, 2021 $157.54B Feb 24, 2023
FY2021 Dec 31, 2020 $165.09B Feb 23, 2022
FY2020 Dec 31, 2019 $152.77B Feb 23, 2021
FY2019 Dec 31, 2018 $140.41B Feb 21, 2020
FY2018 Dec 31, 2017 $137.22B Feb 25, 2019
FY2017 Dec 31, 2016 $129.82B Feb 23, 2018

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $86.98B Feb 25, 2026
FY2025 Dec 31, 2024 $91.47B Feb 25, 2026
FY2024 Dec 31, 2023 $104.74B Feb 26, 2025
FY2023 Dec 31, 2022 $111.60B Feb 22, 2024
FY2022 Dec 31, 2021 $124.29B Feb 24, 2023
FY2021 Dec 31, 2020 $131.53B Feb 23, 2022
FY2020 Dec 31, 2019 $123.81B Feb 23, 2021
FY2019 Dec 31, 2018 $116.94B Feb 21, 2020
FY2018 Dec 31, 2017 $112.62B Feb 25, 2019
FY2017 Dec 31, 2016 $109.34B Feb 23, 2018

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $29.49B Feb 25, 2026
FY2025 Dec 31, 2024 $26.10B Feb 25, 2026
FY2025 Dec 31, 2023 $21.99B Feb 25, 2026
FY2025 Dec 31, 2022 $20.14B Feb 25, 2026
FY2024 Dec 31, 2021 $17.03B Feb 26, 2025
FY2023 Dec 31, 2020 $33.56B Feb 22, 2024
FY2022 Dec 31, 2019 $28.96B Feb 24, 2023
FY2021 Dec 31, 2018 $23.46B Feb 23, 2022
FY2020 Dec 31, 2017 $24.60B Feb 23, 2021
FY2019 Dec 31, 2016 $20.48B Feb 21, 2020

Goodwill

An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $260.00M Feb 25, 2026
FY2025 Dec 31, 2024 $263.00M Feb 25, 2026
FY2024 Dec 31, 2023 $265.00M Feb 26, 2025
FY2023 Dec 31, 2022 $265.00M Feb 22, 2024
FY2022 Dec 31, 2021 $268.00M Feb 24, 2023
FY2021 Dec 31, 2020 $269.00M Feb 23, 2022
FY2020 Dec 31, 2019 $140.00M Feb 23, 2021

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $54.68B Feb 25, 2026
FY2025 Dec 31, 2024 $52.28B Feb 25, 2026
FY2024 Dec 31, 2023 $47.99B Feb 26, 2025
FY2023 Dec 31, 2022 $44.37B Feb 22, 2024
FY2022 Dec 31, 2021 $41.38B Feb 24, 2023
FY2021 Dec 31, 2020 $37.98B Feb 23, 2022
FY2020 Dec 31, 2019 $34.29B Feb 23, 2021
FY2019 Dec 31, 2018 $31.79B Feb 21, 2020
FY2018 Dec 31, 2017 $29.90B Feb 25, 2019
FY2017 Dec 31, 2016 $25.98B Feb 23, 2018

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $6.25B Feb 25, 2026
FY2025 Dec 31, 2024 $6.23B Feb 25, 2026
FY2024 Dec 31, 2023 $4.31B Feb 26, 2025
FY2023 Dec 31, 2022 $3.94B Feb 22, 2024
FY2022 Dec 31, 2021 $5.05B Feb 24, 2023
FY2021 Dec 31, 2020 $5.14B Feb 23, 2022
FY2020 Dec 31, 2019 $4.90B Feb 23, 2021
FY2019 Dec 31, 2018 $4.34B Feb 21, 2020
FY2019 Dec 31, 2017 $3.49B Feb 21, 2020
FY2019 Dec 31, 2016 $4.86B Feb 21, 2020

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 6 Feb 25, 2026
FY2025 Dec 31, 2024 9 Feb 25, 2026
FY2023 Dec 31, 2023 0 Feb 22, 2024
FY2023 Sep 30, 2023 2 Feb 22, 2024
FY2023 Jun 30, 2023 2 Feb 22, 2024
FY2023 Mar 31, 2023 1 Feb 22, 2024
FY2023 Dec 31, 2022 0 Feb 22, 2024
FY2023 Sep 30, 2022 2 Feb 22, 2024
FY2023 Jun 30, 2022 2 Feb 22, 2024
FY2023 Mar 31, 2022 1 Feb 22, 2024

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 6 Feb 25, 2026
FY2025 Dec 31, 2024 9 Feb 25, 2026
FY2023 Dec 31, 2023 0 Feb 22, 2024
FY2023 Sep 30, 2023 2 Feb 22, 2024
FY2023 Jun 30, 2023 2 Feb 22, 2024
FY2023 Mar 31, 2023 1 Feb 22, 2024
FY2023 Dec 31, 2022 0 Feb 22, 2024
FY2023 Sep 30, 2022 2 Feb 22, 2024
FY2023 Jun 30, 2022 2 Feb 22, 2024
FY2023 Mar 31, 2022 1 Feb 22, 2024

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 518.69M Feb 25, 2026
FY2025 Dec 31, 2024 549.96M Feb 25, 2026
FY2025 Dec 31, 2023 578.48M Feb 25, 2026
FY2024 Dec 31, 2022 615.26M Feb 26, 2025
FY2023 Dec 31, 2021 652.13M Feb 22, 2024
FY2022 Dec 31, 2020 692.45M Feb 24, 2023
FY2021 Dec 31, 2019 726.79M Feb 23, 2022
FY2020 Dec 31, 2018 755.29M Feb 23, 2021
FY2019 Dec 31, 2017 780.91M Feb 21, 2020
FY2018 Dec 31, 2016 811.62M Feb 25, 2019